DDIT3 and neoplasm: After 18 days of PM monotherapy (at doses of 5 mg/kg or 10 mg/kg), all mice achieved complete remission, while no mice in the R-CHOP group achieved complete remission, with a tumor inhibition rate of 76.9% (Fig. 1f, Supplementary Table 2).